About Robert Ahlgren
Robert Ahlgren is a director at Immunomic Therapeutics.
Robert Ahlgren first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Ahlgren in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Ahlgren works with at each company, as listed on that company's latest Form D.
Immunomic Therapeutics, Inc. · Form D, Jun 2, 2025
YJ
Yang Gon Jin
Director
SP
Steve Park
Director
DK
Dong-Gun Kim
Executive officer and director
JW
James Wishart
Director
KA
Ki-Hong Ahn
Director
MC
Matthew Chang
Director